Back to search results

Feasibility Testing of the Ventricular Assist Device Anticipatory Guidance Tool

This study is testing a new tool called the Ventricular Assist Device (VAD) Anticipatory Guidance (AG) Tool. This tool aims to better prepare patients for what to expect after receiving a VAD, which is a mechanical pump that helps the heart pump blood in people with advanced heart failure. While there are many resources to help you decide if a VAD is right for you, this tool focuses on understanding life after the implant. Researchers want to see if this tool helps improve patient care by providing more information about satisfaction and concerns at different times after a VAD implant. You may be able to join if you are at least 19 years old, speak English, and are scheduled to receive a VAD. The study will look at what clinicians (healthcare providers) think about the tool in the first two weeks of the study.

Study design
This is an observational study, meaning researchers will observe and collect information without providing specific interventions. It plans to include 10 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoint, clinician perspectives, is measured at the first two weeks of study initiation. Patient follow-up beyond this is not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06823583

Multi-Site Feasibility Testing of the Ventricular Assist Device Anticipatory Guidance Tool

Recruiting
Not specifiedAges 19+Observational
Bryan Heart
~10 participants
Updated 2025-09-19 on ClinicalTrials.gov

At a glance

Recruiting sites
1 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Clinician perspectives
Measured over First two weeks of study initiation.

Conditions

Ventricular Assist Device
Advanced Heart Failure
Anticipatory Guidance

Explore related trials

Heart Failure

NCT06823583

Where you'd take part

This study runs at 2 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Advocate Aurora Health

    Milwaukee, Wisconsinstudy coordinator listed

    Not yet recruiting

  • Bryan Heart

    Lincoln, Nebraskastudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Mathue Baker, MD · STUDY_CHAIR · Bryan Heart

Who to contact

Sarah E Schroeder, PhD, MSN, BSN, RN-Diploma
[email protected]
402-481-8450
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

scheduled for a VAD implantation
English-speaking as the VAD AG Tool v5.0 has not yet been translated beyond English age ≥19 years at the time of implant as most states in North America have an age of majority for consent signing.

Exclusion

Not scheduled for VAD surgery
Non English speaking
\<19 yrs of age (Not a VAD Clinician for the clinician evaluation process)

What this trial measures

  • Clinician perspectivesFirst two weeks of study initiation.

    Evaluate clinician perspectives of the Ventricular Assist Device Anticipatory Guidance Tool (VAD AG Tool) v5.0 for accuracy, by completing an evaluation where each item will be scored 1-4, as follows: 1 Not Relevant, 2 Somewhat Relevant, 3 Quite Relevant, 4 Highly Relevant